Vanda Pharmaceuticals VNDA Balance Sheet (2010-2026)

NASDAQ VNDA
$4.08 -0.01 (-0.24%)
At close: Nov 10, 2026 · 4:00 PM EST
Reported Financials

Vanda Pharmaceuticals Quarterly Balance Sheet

Periods 66 quarters
Latest Sep 2026

Vanda Pharmaceuticals reported total assets of $382.33M and total liabilities of $182.47M for the quarter ended Sep 2026, down 36.4% year over year. This balance sheet covers 66 quarters of results from Jun 2010 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
52.07M66.93M58.23M49.40M135.03M354.17M150.03M183.19M135.82M125.16M102.95M100.50M102.32M111.80M80.98M70.02M84.85M54.03M55.88M61.93M
Short-term InvestmentsInvestments (Current)
380.74M368.25M382.63M405.39M331.83M147.33M339.32M306.67M252.44M268.98M284.72M275.76M272.33M229.11M244.57M223.73M179.00M148.28M114.15M78.56M
Cash & Current Investments
432.81M435.18M440.86M454.79M466.86M501.50M489.35M489.86M388.26M394.14M387.68M376.26M374.64M340.91M325.55M293.75M263.85M202.31M170.03M140.49M
Receivables - NetNet Receivables
32.47M30.50M28.81M29.35M33.51M24.51M33.62M29.27M34.16M36.71M41.86M42.75M47.10M44.60M44.99M50.54M54.58M56.88M59.69M60.32M
Receivables - OtherOther Receivables
Receivables
32.47M30.50M28.81M29.35M33.51M24.51M33.62M29.27M34.16M36.71M41.86M42.75M47.10M44.60M44.99M50.54M54.58M56.88M59.69M60.32M
Raw Materials
Work In Process
Finished Goods
Inventory
8.25M9.28M9.60M11.06M11.49M10.69M10.18M10.24M10.21M9.92M9.52M9.54M9.51M10.28M10.36M10.04M11.02M10.51M10.13M9.65M
Current Deferred Tax AssetsCurrent Deferred Tax
Prepaid Assets
12.00M25.31M25.74M21.37M17.73M6.59M9.45M16.44M9.17M7.07M8.17M11.76M15.42M20.48M22.21M21.16M26.99M32.28M33.09M36.13M
Current Assets
478.30M492.27M496.90M507.11M519.29M533.71M533.50M536.57M432.95M439.43M439.18M432.39M438.89M407.91M394.92M367.50M347.26M293.17M264.48M238.47M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
3.11M2.92M2.75M2.59M2.57M2.33M2.16M2.13M2.04M2.31M2.30M2.18M2.13M2.44M2.42M2.46M2.25M2.25M2.58M3.03M
Long-Term Investments
Intangibles
20.08M19.70M19.32M18.94M18.57M18.19M17.81M17.43M121.37M119.35M117.60M115.85M114.10M112.34M110.59M108.84M117.09M115.10M113.12M111.13M
Goodwill & Intangibles
20.08M19.70M19.32M18.94M18.57M18.19M17.81M17.43M121.37M119.35M117.60M115.85M114.10M112.34M110.59M108.84M117.09M115.10M113.12M111.13M
Long-Term Deferred Tax
74.88M70.80M72.69M74.53M74.04M71.75M70.48M67.77M75.00M75.34M76.56M79.36M81.44M89.15M97.14M103.07M
Other Non-Current Assets
Non-Current Assets
115.49M111.29M112.21M114.68M114.96M110.83M108.18M105.03M215.49M213.26M212.19M212.73M217.31M224.03M229.83M233.64M141.69M140.36M147.98M143.86M
Assets
593.79M603.56M609.10M621.79M634.25M644.53M641.68M641.61M648.44M652.68M651.37M645.12M656.20M631.94M624.75M601.14M488.95M433.53M412.47M382.33M
Liabilities
Current Liabilities
Accounts Payables
34.44M51.39M50.24M50.13M45.55M35.09M31.93M32.60M38.46M37.77M39.60M39.30M39.09M45.28M57.12M47.62M68.30M60.62M69.99M60.59M
Payables
34.44M51.39M50.24M50.13M45.55M35.09M31.93M32.60M38.46M37.77M39.60M39.30M39.09M45.28M57.12M47.62M68.30M60.62M69.99M60.59M
Accumulated Expenses
Other Accumulated Expenses
39.98M39.35M38.16M42.50M45.89M58.70M55.47M52.24M49.24M55.57M54.19M49.79M60.90M58.64M64.37M70.25M76.87M74.96M94.03M94.39M
Current Taxes
Current Deferred Revenue
Total Current Liabilities
74.42M90.74M88.40M92.62M91.44M93.79M87.40M84.84M87.70M93.34M93.79M89.09M99.98M103.92M121.49M117.87M145.16M135.58M164.03M154.98M
Non-Current Liabilities
Capital Leases
3.15M2.95M3.08M2.81M4.08M3.79M3.18M2.35M
Non-Current Deferred Revenue
Operating Leases
10.06M9.66M9.29M8.90M8.81M8.39M7.94M7.47M7.01M6.51M6.01M5.49M4.94M4.40M3.88M3.42M2.99M3.27M15.03M14.95M
Other Non-Current Liabilities
4.39M1.03M2.87M4.61M6.80M6.61M6.45M6.20M8.83M8.83M9.06M9.32M9.59M9.25M9.97M11.04M9.53M10.13M10.05M10.20M
Total Non-Current Liabilities
84.47M100.40M97.69M101.53M100.25M102.18M95.34M92.31M94.70M99.86M99.80M94.58M108.07M111.27M128.45M124.10M152.23M142.63M182.23M172.27M
Total Liabilities
88.86M101.44M100.55M106.13M107.05M108.79M101.78M98.51M103.53M108.69M108.86M103.89M117.66M120.52M138.42M135.14M161.76M152.76M192.28M182.47M
Shareholder's Equity
Common Equity
504.93M502.12M508.55M515.66M527.20M535.74M539.90M543.10M544.91M544.00M542.52M541.22M538.55M511.42M486.33M466.00M327.19M280.77M220.19M199.86M
Liabilities and Shareholders Equity
593.79M603.56M609.10M621.79M634.25M644.53M641.68M641.61M648.44M652.68M651.37M645.12M656.20M631.94M624.75M601.14M488.95M433.53M412.47M382.33M
Retained Earnings
-164.18M-170.61M-168.03M-164.76M-157.90M-154.65M-153.13M-152.99M-155.39M-159.54M-164.06M-169.38M-174.29M-203.79M-230.99M-253.58M-394.77M-443.33M-505.85M-528.41M

Vanda Pharmaceuticals Balance Sheet API

Pull Vanda Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=VNDA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY